Current Filters

Showing 61 - 70 results of 3489

Dimethyl fumarate (Tecfidera) (Last Updated: Feb 4, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Tecfidera
Manufacturer:
Biogen Idec Canada Inc.
Submission Type:
Initial
Indications:

Multiple Sclerosis, relapsing

Nebivolol (Bystolic) (Last Updated: Feb 4, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Bystolic
Manufacturer:
Forest Laboratories Canada Inc.
Submission Type:
Initial
Indications:

Hypertension, essential

Linagliptin-metformin (Jentadueto) (Last Updated: Mar 8, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Jentadueto
Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
Submission Type:
Initial
Indications:

Diabetes mellitus (Type 2)

Boceprevir (Victrelis) (Last Updated: Dec 21, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Victrelis
Manufacturer:
Merck Canada Inc.
Submission Type:
Request For Advice
Indications:

Hepatitis C, chronic

Telaprevir (Incivek) (Last Updated: Jan 2, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Incivek
Manufacturer:
Vertex Pharmaceuticals Canada Inc.
Submission Type:
Request For Advice
Indications:

Hepatitis C, chronic

Adalimumab (Humira) (Last Updated: Feb 4, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Humira
Manufacturer:
AbbVie Corporation
Submission Type:
Initial
Indications:

Arthritis, Juvenile Idiopathic

Eculizumab (Soliris) (Last Updated: Jan 7, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Soliris
Manufacturer:
Alexion Pharma Canada
Submission Type:
Initial
Indications:

Hemolytic Uremic Syndrome, Atypical

Glycopyrronium bromide (Seebri) (Last Updated: Nov 30, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Seebri
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Submission Type:
Initial
Indications:

Chronic Obstructive Pulmonary Disease (COPD), maintenance bronchodilator treatment

Abatacept (Orencia) (Last Updated: Nov 29, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Orencia
Manufacturer:
Bristol-Myers Squibb Canada
Submission Type:
Initial
Indications:

Arthritis, Rheumatoid

Interferon beta-1a (Rebif) (Last Updated: Mar 8, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Rebif
Manufacturer:
EMD Serono
Submission Type:
Initial
Indications:

Clinically Isolated Syndrome

Download results as CSV